// App-Quantinova.ai

: Characteristics of prominent response to triple therapy in patients with asthma uncontrolled on ICS/LABA: A stratified analysis of the TRIMARAN and TRIGGER studies

Researchers

Presenter

  • Dave Singh

Principal Investigators

  • J. Christian Virchow

  • Walter G. Canonica

  • Sandrine Corre

  • Florence Zuccaro

  • Maxim Kots

  • Andrea Vele

  • George Georges

  • Stefano Petruzzelli

Medical Centers

  • Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom,

  • Department of Pneumology/Intensive Care Medicine, University of Rostock, Rostock, Germany.

  • Humanitas University and Humanitas Research Hospital, Milano, Italy

  • Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy.

Locations

  • United Kingdom

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Parallel Group

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved